Are you Dr. Hibberd?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 60 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
725 Albany St Ste 9b C
Shapiro Bldg
Boston, MA 02118Phone+1 617-414-4290Fax+1 617-414-4285
Summary
- Dr. Patricia Hibberd, MD is an infectious disease specialist in Boston, Massachusetts. She is currently licensed to practice medicine in Massachusetts. She is affiliated with Boston Medical Center and Massachusetts General Hospital.
Education & Training
Massachusetts General HospitalResidency, Internal Medicine, 1986 - 1992
Harvard Medical SchoolClass of 1986
Certifications & Licensure
MA State Medical License 1988 - 2025
Clinical Trials
- Probiotics to Enhance Immunogenicity of Influenza Vaccine in Healthy Adults Start of enrollment: 2007 Sep 01
- Safety of Lactobacillus Rhamnosus GG ATCC 53103 (LGG) in Healthy Volunteers Start of enrollment: 2009 Dec 01
- Maternal Newborn Health Registry Start of enrollment: 2008 May 01
- Join now to see all
Publications & Presentations
PubMed
- Does Engagement in HIV Care Affect Screening, Diagnosis, and Control of Noncommunicable Diseases in Sub-Saharan Africa? A Systematic Review and Meta-analysis.Emma M Kileel, Amy Zheng, Jacob Bor, Matthew P Fox, Nigel J Crowther
AIDS and Behavior. 2024-02-01 - 3 citationsIn-hospital mortality risk stratification in children aged under 5 years with pneumonia with or without pulse oximetry: A secondary analysis of the Pneumonia REsearch ...Shubhada Hooli, Carina King, Eric D McCollum, Tim Colbourn, Norman Lufesi
International Journal of Infectious Diseases. 2023-04-01 - 4 citationsCost-effectiveness of low-dose aspirin for the prevention of preterm birth: a prospective study of the Global Network for Women's and Children's Health Research.Jackie K Patterson, Simon Neuwahl, Norman Goco, Janet Moore, Shivaprasad S Goudar
The Lancet. Global Health. 2023-03-01
Press Mentions
When 'Friendly' Probiotic Bacteria Turn into Foes in the ICUNovember 29th, 2019
AixSwiss Delivers Transparency with Unique QR Code That Shows Lab Results for Nupure ProbiflorSeptember 18th, 2018
Safety of Probiotic Supplements Is Not Guaranteed, Study SaysJuly 16th, 2018- Join now to see all
Grant Support
- Improving Quality Of Care For The Treatment Of Childhood PneumoniaEunice Kennedy Shriver National Institute Of Child Health &Human Development2010–2012
- Probiotics To Enhance Influenza Vaccine ImmunogenicityNational Center For Complementary &Alternative Medicine2010–2011
- Midcareer Investigator Award In Patient-Oriented Research (K24)National Center For Complementary &Alternative Medicine2010–2011
- Probiotics To Eradicate Nasal S Aureus In ESRD PatientsNational Center For Complementary &Alternative Medicine2005–2011
- Effects Of Probiotics In Patients With Cystic FibrosisNational Center For Complementary &Alternative Medicine2010
- Improving Quality Of Care For The Treatment Of Childhood PneumoniaEunice Kennedy Shriver National Institute Of Child Health &Human Development2008–2009
- Midcareer Investigator Award In Patient-Oriented Research (K24)National Center For Complementary &Alternative Medicine2006–2009
- Effects Of Probiotics In Patients With Cystic FibrosisNational Center For Complementary &Alternative Medicine2006–2009
- Developing Probiotics As Foods And Drugs - Scientific And Regulatory ChallengesNational Center For Complementary &Alternative Medicine2006
- Open-Label, Dose Escalation Phase 1 Study To Eval Clostrodium Difficile Toxin ANational Center For Research Resources2005
- Effects Of Probiotics In Patients With Cystic FibrosisNational Center For Complementary &Alternative Medicine2004–2005
- Probiotics To Eradicate Nasal S Aureus In ESRD PatientsNational Center For Complementary &Alternative Medicine2004
